Recent

% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • dr.vinmantoo dr.vinmantoo Feb 5, 2013 1:08 PM Flag

    SNTA looks good heading into ASCO, what else are you buying/holding?

    The PPHM trial irregularities are certainly not addressed, and you are kidding yourself if you think there isn't something very fishy with the placebo arm.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Yes, I know the risks here with PPHM!
      But, overall, I view their cancer drug in the same light as ours (Synta's) and Thresholds...
      All three are first or best in class new cancer drugs with potentially broad usage for many cancer types and therefore massive potential.
      I put Ganetespib's odds as the best of the three--next is Threshold's TH-302, and PPHM's drug (bavi) is at the bottm

 
SNTA
0.3934+0.0046(+1.18%)May 5 4:00 PMEDT